4896 — K Pharma Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for K Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 189 | 1,337 | 3,266 | 2,268 | 2,792 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 205 | 1,371 | 3,309 | 2,348 | 2,891 |
| Other Long Term Assets | |||||
| Total Assets | 206 | 1,375 | 3,314 | 2,353 | 2,939 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23.4 | 33.7 | 178 | 63.5 | 102 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.9 | 38.3 | 209 | 94.8 | 1,674 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 179 | 1,336 | 3,105 | 2,258 | 1,265 |
| Total Liabilities & Shareholders' Equity | 206 | 1,375 | 3,314 | 2,353 | 2,939 |
| Total Common Shares Outstanding |